Mycophenolic acid and Pancreas transplant rejection - a phase IV clinical study of FDA data

Summary:

Pancreas transplant rejection is found among people who take Mycophenolic acid, especially for people who are male, 20-29 old, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people take Mycophenolic acid and have Pancreas transplant rejection. It is created by eHealthMe based on reports of 11,056 people who have side effects when taking Mycophenolic acid from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 28, 2022

11,056 people reported to have side effects when taking Mycophenolic acid.
Among them, 20 people (0.18%) have Pancreas transplant rejection.

What is Mycophenolic acid?

Mycophenolic acid has active ingredients of mycophenolic acid. eHealthMe is studying from 11,068 Mycophenolic acid users for its effectiveness, alternative drugs and more.

What is Pancreas transplant rejection?

Pancreas transplant rejection is found to be associated with 119 drugs and 47 conditions by eHealthMe.

Number of Mycophenolic acid and Pancreas transplant rejection reports submitted per year:

Could Mycophenolic acid cause Pancreas transplant rejection?

Time on Mycophenolic acid when people have Pancreas transplant rejection *:

Gender of people who have Pancreas transplant rejection when taking Mycophenolic acid *:

female: 26.32 %
male: 73.68 %

Age of people who have Pancreas transplant rejection when taking Mycophenolic acid *:

Common drugs people take besides Mycophenolic acid *:

Heparin: 8 people, 40.00%
Prograf: 7 people, 35.00%
Acetylsalicylic Acid: 7 people, 35.00%
Sulfamethoxazole And Trimethoprim: 5 people, 25.00%
Prednisolone: 5 people, 25.00%
Sandimmune: 2 people, 10.00%
Envarsus Xr: 2 people, 10.00%
Tacrolimus: 1 person, 5.00%
Rapamune: 1 person, 5.00%
Nitroglycerin: 1 person, 5.00%

Common side effects people have besides Pancreas transplant rejection *:

Haematoma (collection of blood outside the blood vessels): 7 people, 35.00%
Oral Herpes (viral infection of mouth): 7 people, 35.00%
Upper Respiratory Tract Infection: 7 people, 35.00%
Respiratory Tract Inflammation: 7 people, 35.00%
Hyperlipidaemia (presence of excess lipids in the blood): 7 people, 35.00%
Pancreatic Abscess: 2 people, 10.00%
Urinary Tract Infection: 2 people, 10.00%
Tachyarrhythmia (disturbance of the heart rhythm in which the heart rate is abnormally increased): 2 people, 10.00%
Renal Failure Acute (rapid kidney dysfunction): 2 people, 10.00%
Impaired Healing: 2 people, 10.00%

Common conditions people have *:

Type 1 Diabetes: 7 people, 35.00%
Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 25.00%
Immunodeficiency Disorders: 2 people, 10.00%
Hepatitis C: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolic acid and have Pancreas transplant rejection?

Check whether Pancreas transplant rejection is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Common Mycophenolic acid side effects:

Browse all side effects of Mycophenolic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Pancreas transplant rejection treatments and more:

Pancreas transplant rejection (257 reports)

COVID vaccines that are related to Pancreas transplant rejection:

All the drugs that are associated with Pancreas transplant rejection:

Pancreas transplant rejection (119 drugs)

All the conditions that are associated with Pancreas transplant rejection:

Pancreas transplant rejection (47 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolic acid (the active ingredients of Mycophenolic acid) and Mycophenolic acid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.